On December 3, underage students at Bolashaq Academy received their first dose of Pfizer’s Comirnaty vaccine against coronavirus infection in Polyclinic 1. Students felt well after the vaccine and had no adverse reactions. Students will receive a second dose of Comirnaty (Pfizer) 21 days after the first dose.
You may also like
On April 21, 2021 Abylbayeva B.A., the senior teacher of the Kazakh language and literature department of the Academy “Bolashaq” conducted an […]
Dear students and teachers of the BOLASHAQ Academy! With pride and great joy, we want to share great news: on February 29, […]
03.10. in groups of the Department of Pharmaceutical Disciplines, a conversation was held on the relevant topic “Drug Addiction & Our Future” […]
The Independent Quality Assurance Agency for Education (IQAA) is conducting an external program accreditation audit of the Eurasian Humanities Institute (Nur-Sultan) from […]